Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

o increase between 30% and 40% from 2008 to the range from $16.6 million to $17.9 million.

    Highlights of Recent Developments
    -- Management has decided to start the construction of Inner Mongolia
       plant buildings on May 9, 2009 and to attempt to complete it by the end
       of 2009.
    -- In addition to the cost of land use rights and related expenses
       (approximately $32.6 million) which Liang Fang has paid, other
       components of the project are yet to be funded, including construction
       costs of approximately $17.5 million, costs associated with the various
       production lines estimated at approximately $33.6 million and working
       capital of approximately $7.3 million.
    -- The Company entered into an intellectual rights transfer contract with
       Beijing Yipuan Bio-Medical Technology Co., Ltd. in December 2008 to
       acquire the drug Yipubishan, a highly effective and stable octreotide
       acetate injection solution, In the first quarter of 2009, the Company
       has paid up $7.9 million as required in the transfer. The Company
       believes this could contribute $11.0 million to 2009's sale revenues
       with net margin of 75%.
    -- The Company announced two drugs entering into clinical testing of SFDA
       in 2008, Isosorbide Mononitrate sustained release tablet, a highly
       effective drug for the prevention and treatment of angina; and
       Laevo-Bambutero a Class 1 drug to treat asthma.
    -- Lotus obtained the patent, along with exclusive production rights for
       Laevo-Bambutero in China, through the technology transfer agreement
       with Dongguan Kaifa for a cash payment of $7.0 million and a 3% royalty
       on products sales. The Company has already paid $2.9 million to
       Dongguan Kaifa. The Company intends to market Laevo-Bambutero as a
       better alternative to Bambutero for the treatment of asthma, since it
       uses an integra
'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of the National ... Informatics at Columbia University School of Nursing. A member of the Institute of ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... from 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland ... opportunities will be attending from across the country. All specialties will be represented. ...
(Date:9/1/2015)... ... September 01, 2015 , ... AdvantagePlusCaregivers.com® ... to access caregivers and what to look for and expect when searching for ... Founded in 2006 in Canoga Park, CA by CEO, Richard Weatherman and Co-Founder ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... information about new patients directly from Practice Perfect to FOTO enabling cost and ... , Steven Presement, President of Practice Perfect, stated "FOTO is ...
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. ... help make things easier for parents, caregivers and children too. Here are three reasons ... big and small become more fluid. When a routine is implemented into a child’s ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2
... dose delivered to the prostate and nearby organs in ... CT or MRI and uniformly documented in every patient, ... Ph.D., director of Medical Physics in the department of ... was issued by a task group commissioned by the ...
... ignore guidelines, recommend screening to women at low risk, ... In 2002 and 2003, screening guidelines for the ... than one-third of U.S. primary care physicians follow those ... overprescribe the screen, telling researchers that they would recommend ...
... ... on prostate cancer testing, clarifying the Association,s recommendations and support of early detection. ... (Vocus) November 2, ... prostate cancer testing. We are concerned that these reports are causing significant confusion for ...
... Palsy (UCP) of Central Arizona has an extraordinary corporate ... beneficiary of Circle K,s community involvement for over twenty-five ... the largest corporate sponsor for the organization that provides ... various disabilities including cerebral palsy, autism, Down syndrome, developmental ...
... BRYAN, Texas, Nov. 2 The director of the Planned ... job. Abby Johnson had worked at the clinic for eight ... of heart about abortion. The Planned Parenthood clinic was the ... the fall of 2004, and the prayer and fasting initiative ...
... of American children received nutrition assistance, analysis shows , MONDAY, ... of all American children and teens will live in a ... Researchers analyzed 30 years (1968 to 1997) of national data ... that by the time they were 1 year old, 12.1 ...
Cached Medicine News:Health News:Task force develops new radiation guidelines for brachytherapy 2Health News:Doctors Overprescribing the Pap Test 2Health News:Doctors Overprescribing the Pap Test 3Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 2Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 3Health News:Circle K Aces High Golf Tournament - Furthering Life without Limits for People with Disabilities 2Health News:Planned Parenthood Director Quits Abortion Business, Experiences Conversion at Starting Place of 40 Days for Life 2Health News:Food Stamps Help Stave Off Hunger in Many U.S. Homes 2
(Date:8/31/2015)... VIEW, Calif. , Aug. 31, 2015 /PRNewswire/ ... for flow cytometry is experiencing a rise in ... the demand in underdeveloped nations to quantitate CD4 ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... Analysis of the Global Flow Cytometry Market ( ...
(Date:8/31/2015)... HARRISBURG, Pa. , Aug. 31, 2015 ... been reversed statewide since Pennsylvania ... the life-saving drug kits, naloxone. Heroin and ... in Pennsylvania , killing more individuals ... 2013, approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015  The departments of ... event today at Gaudenzia Concept 90 to raise awareness ... overdose crisis in Pennsylvania and ... and focus on recovery through the Building Bridges ... Pennsylvanians are dying every day to a disease that ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Phase 1 Colorectal and Prostate Cancer,Trials To Be ... FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, ... announced that data from a Phase 2 trial,of ... small cell lung cancer (SCLC) will be presented ...
... Urine Flow, With,Long Lasting Effect in Phase 2 ... Spectrum,Pharmaceuticals, Inc., today announced Phase 2 safety and ... the treatment,of benign prostatic hypertrophy (BPH), at the ... Convention Center in,Anaheim, California on Tuesday, May 22, ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: